1 / 68

India Patient Support Programs (PSP) Market Analysis

This report presents a strategic analysis of the India Patient Support Programs (PSP) Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the India Patient Support Programs (PSP) Market, and offers unmatched value, accuracy, and expert insights.

Insights10
Download Presentation

India Patient Support Programs (PSP) Market Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A sample report on India Patient Support Programs (PSP) Market Analysis

  2. This report presents a strategic analysis of the India Patient Support Programs (PSP) Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the India Patient Support Programs (PSP) Market, and offers unmatched value, accuracy, and expert insights.

  3. Report Scope Report Attribute Details Number of Pages 70-80 Base Year for Estimation 2023 Forecast Period 2024-2030 Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario Report Coverage Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Research Approach Secondary Research (60%), Primary Research (40%) Click on the icon to know the detailed methodology 3 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  4. Table of Content CONTENT PG. NO. 07-17 1. India Patient Support Programs (PSP) Market Overview 1.1. Patient Support Programs (PSP) Overview 1.2. Patient Support Programs (PSP) Scenario in the World 1.3. India Overview 1.4. Economic Overview: India 1.5. Statistics at a Glance 1.6. Healthcare Scenario in India 1.7. Budget of Indian Government for Public Insurance 1.8. Top Developments in India 18-21 2. Patient Support Programs (PSP) Overview 2.1. Categories of Patient Support Programs 2.2. PSP Landscape in India 2.3. PSP Model in India 4 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  5. Table of Content CONTENT PG. NO. 22-27 3. Market Size and Forecasting 3.1. Market Size and Forecasts (Excel and Methodology) 3.2. Market Segmentation 3.2.1. Therapeutic Area 3.2.2. Type 28-33 4. Market Dynamics 4.1. Market Growth Drivers 4.2. Market Restraints 34-43 5. Competitive Landscape 5.1. Major Market Share 5.2. Key Players in India Patient Support Programs (PSP) Market 5.2.1. Janssen Pharmaceutical 5.2.2. Roche 5 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  6. Table of Content CONTENT PG. NO. 5.2.3. Pfizer 5.2.4. Sanofi 5.2.5. Novartis 5.2.6. Takeda 5.2.7. Biocon Ltd 5.2.8. Dr. Reddy’s Laboratories 5.2.9. Cipla 5.2.10. Lupin 44-48 6. Regulatory Landscape 6.1. Regulations in India 6.2. Reimbursement Process 6 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  7. India Patient Support Programs (PSP) Market Analysis 1. Market Overview

  8. 1.1 Patient Support Programs ▪ Patient Support Programs (PSPs) encompass initiatives led by pharmaceutical companies, aimed at enhancing access, usage, and adherence to prescription drugs ▪ Patient support programs assist patients in obtaining necessary medications and educate them on proper usage, thereby increasing the likelihood of successful treatment ▪ By providing crucial information upon initial prescription and offering continuous support throughout the treatment process, PSPs aim to enhance healthcare for clients and ensure an improved overall experience Types of services provided by a PSPs: PSPs can encompass a wide range of services, such as: Temporary Supply Assistance: Offers a short-term supply of free product while awaiting coverage approval on your plan ▪ Financial Assistance: Assists with remaining costs after processing drug plan coverage ▪ Nursing Services: Offers education, follow-up calls, or appointment coordination ▪ Pharmacy Services: Coordinates drug shipment, dispensing, and delivery ▪ Clinical Services: Provides drug administration (e.g., infusion or injection) and lab services if necessary ▪

  9. 1.2 Patient Support Programs Scenario in the World Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic ▪ 1,589 Global Patient Support Programs (PSPs) were recorded as of April, 2020 57% Consumers prioritize ongoing support for medication management and dosage accuracy In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 71% Of consumers consider it very important for pharmaceutical companies to offer good customer support $528 Bn Is the annual cost associated with morbidity and mortality due to poor medication adherence Illustrative Illustrative 9 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  10. 1.2 Patient Support Programs Scenario in the World Regional Analysis ➢ Africa: $_ _ ➢ APAC: $_ _ ➢ Europe: $_ _ ➢ LATAM: $_ _ ➢ Middle East: $_ _ India Market ~$xx Bn Market ➢ North America: $_ _ Illustrative Illustrative 10 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  11. 1.3 India Overview Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic ▪ 1.42 Bn Is the population of India in 2023 $3.92 Tn Is the Gross Domestic Product of India in 2023 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 28.2 years Is the median age in India in 2023 2.6% Of India’s GDP is spent on health in 2023 Illustrative Illustrative 11 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  12. 1.4 Economic Overview: India Population of India, (In Bn) GDP of India, (in $Tn) 1.42 $3.92 1.41 1.41 $3.42 $3.15 1.39 $2.84 1.38 $2.70 $2.67 $2.65 $2.29 1.36 1.35 1.33 2016 2017 2018 2019 2020 2021 2022 2023 2016 2017 2018 2019 2020 2021 2022 2023 Population Split (2023) In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ By Gender By Age Group In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 25.3% 25.3% 0-14 Yrs 15-64 Yrs 65+ Yrs Female 48% Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Male 52% 67.8% Illustrative Illustrative 12 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  13. 1.5 Statistics at a Glance: Patient Support Programs Market in India In this section you will get an understanding of the patient support programs market, which includes important statistics and other details related to the topic ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ 49% Patient in India suffering from non-communicable diseases do not adhere to their medications 96% Doctors in India feel that Patient Support Programs can improve patient outcomes In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 75% Pharmaceuticals in India have outsourced their Patient Support Program 1759 Drugs are offered through the government Patient Assistance Program in India Illustrative Illustrative 13 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  14. 1.6 Healthcare Scenario in India Public Healthcare ▪ Public sector includes government-funded healthcare facilities such as primary health centers, district hospitals, and tertiary care hospitals ▪ Urban areas generally have better healthcare facilities, including multi-specialty hospitals and advanced medical technology Private Healthcare ▪ Private sector consists of private hospitals, clinics, and diagnostic centers, which cater to a significant portion of the population ▪ These offer a wider range of services that are of higher quality with short wait times but come at a greater cost Insurance Government Programs ▪ Government has launched various initiatives to improve healthcare in India ▪ These include the National Health Mission, which aims to provide accessible, affordable, and quality healthcare to all citizens ▪ Additionally, there is an ongoing focus on digital health initiatives and telemedicine services to enhance healthcare accessibility Public: Government has implemented schemes like Ayushman Bharat, which aims to provide health insurance coverage to economically vulnerable sections of the population ▪ Private: Private insurance companies offer health insurance policies that cover medical expenses ▪ Illustrative Illustrative 14 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  15. 1.7 Budget of Indian Government for Public Insurance Proposed Budget By Category 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31 Outlays $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633 In Billions Of Dollars Medicare 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7% As % Of GDP National Health Expenditures (NHE) grew 2.7% to $4.3 Tn in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) ▪ Medicare spending grew 8.4% to $900.8 Bn in 2021, or 21% of total NHE ▪ Private health insurance spending grew 5.8% to $1,211.4 Bn in 2021, or 28% of total NHE ▪ Out of pocket spending grew 10.4% to $433.2 Bn in 2021, or 10% of total NHE ▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 Bn, or 14% of total NHE ▪ Hospital expenditures grew 4.4% to $1,323.9 Bn in 2021, slower than the 6.2% growth in 2020 ▪ Physician and clinical services expenditures grew 5.6% to $864.6 Bn in 2021, slower growth than the 6.6% in 2020 ▪ Prescription drug spending increased 7.8% to $378.0 Bn in 2021, faster than the 3.7% growth in 2020 ▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% ▪ Illustrative Illustrative 15 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  16. 1.8 Top Developments in India Latest Deals in India Amount / Duration Company Name Type Year Key Pointers Lupin Limited has introduced Humrahi, a patient support program that marks the beginning of a new era in diabetes management by focusing on adherence, behavior, and transformation It provides extensive support by focusing on essential aspects of therapy adherence, including personalized diet counseling, medication assistance, and customized lifestyle modifications, all overseen by healthcare professionals ▪ New Launch - 2023 ▪ Takeda has introduced the Sunrise Patient Services Program for Hereditary Angioedema (HAE) in India This patient support program focuses on four key elements: Awareness, Screening & Diagnosis, Treatment, and Maintenance Support Implemented by an independent patient services agency funded by Takeda, the program offers field counseling and tele-support services, free HAE testing at quality diagnostic labs, and assistance with treatment reimbursement, among other services ▪ ▪ New Launch - 2023 ▪ Illustrative Illustrative 16 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  17. 1.8 Top Developments in India (Continued) Latest Deals in India Amount / Duration Company Name Type Year Key Pointers Illustrative Illustrative 17 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  18. India Patient Support Programs (PSP) Market Analysis 2. Patient Support Programs Overview

  19. 2.1 Categories of Patient Support Programs Adherence Support Financial Assistance Clinical Support Target patients' medication persistence, particularly in cases involving complex regimens, side effects, and conditions where treatment effects may not be immediately evident ▪ Focus on alleviating financial and affordability concerns for patients, whether at the onset or continuation of treatment Provide aid to patients who face barriers in traveling for treatment administration or accessing hospitals for clinical needs ▪ ▪ Provide guidance and assistance in navigating regulatory changes, establishing funding avenues, and managing financial aid for eligible patients, all while ensuring adherence to regulatory requirements ▪ Address a range of challenges including drug accessibility, management of clinical workload, and overcoming transportation limitations for patients, ensuring comprehensive support for the successful delivery of treatment ▪ Offer comprehensive support including education on adherence, counseling, assistance with adverse event reporting, and resources to help healthcare professionals effectively manage patient adherence ▪ 19 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  20. 2.2 PSP Landscape in India PSPs in India are provided by top global and local companies and the most common mode is by outsourcing it to third-party providers Engagement types commonly used by these PSPs include Telephonic services, in-person consultations and mixed approach ▪ ▪ Therapeutic Areas Addressed by PSPs in India, (in %), 2023 Mode of Pharmaceutical PSPs in India, (in %), 2023 25% TB Diabetes Hep B Respiratory Cancer Hairfall IBD 75% Anemia Outsourced Not outsourced 20 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  21. 2.3 PSP Model in India For Pharmaceuticals Profile Patient Outsource Evaluate Profiling eligible patients Outsourcing to third-party agencies Audit the provision of services Studying patient journey For Patients Financial Assistance Round the Clock Support Home Delivery Services Caregiver Education 21 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  22. India Patient Support Programs (PSP) Market Analysis 3. Market Size and Forecasting

  23. 3.1 Market Size and Forecasts (Excel and Methodology) India Patient Support Programs (PSP) Market Forecast, 2023-2030 In this section you will get an understanding of the topic, which includes the number of patient support programs, therapeutic areas, and other details related to the topic ▪ XX Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ 2023 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 2023 2024 2025 2026 2027 2028 2029 2030 Major Markets Patient ($Mn) Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12 India Patient Size ($Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73 % of Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45% Global Market Size ($Bn) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937 Click on the icon to know the calculations and assumption India Market Size ($Bn) 61 74 84 87 91 95 99 106 Illustrative Illustrative 23 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  24. 3.2 Snapshot of Patient Support Programs Market Segmentation Therapeutic Area Type Oncology Financial Assistance Neurology Medication Adherence Diabetes Support Services Rare Diseases Others Others In this section you will get an understanding of the segmentations which will cover the India Patient Support Programs (PSP) Market ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Illustrative Illustrative 24 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  25. 3.2.1 Market Segmentation: By Therapeutic Area In this section you will get an understanding of the topic, which includes the segmentation of the Indian Patient Support Program Market based on Therapeutic Area ▪ India Patient Support Programs (PSP) Market Share, By Therapeutic Area (2023) Others Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Oncology Rare Diseases In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Diabetes Neurology Illustrative Illustrative 25 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  26. 3.2.2 Market Segmentation: By Type In this section you will get an understanding of the topic, which includes the segmentation of the Indian Patient Support Program Market based on Type ▪ India Patient Support Programs (PSP) Market Share, By Type (2023) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Others Financial Assistance In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Support Services Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Medication Adherence Illustrative Illustrative 26 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  27. India Patient Support Programs (PSP) Market Analysis 4. Market Dynamics

  28. 4. Snapshot Of Market Growth Drivers And Restraints 4.1.1 4.1.2 4.1.3 Growing need to manage chronic diseases with highest mortality rate of ~70% in India Rising focus of patients on personalized and patient-centric care Rapidly aging population of 153 Mn creating demand for PSPs 4.2.1 4.2.2 Increasing use of digital tools in PSPs raises concerns about data privacy and security Limited awareness and lack of integration Illustrative Illustrative 28 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  29. 4.1.1 Growing need to manage chronic diseases with highest mortality rate of ~70% in India Burden of Chronic Diseases in India, (%) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Cancer Diabetes Obesity Hypertension Others Illustrative Illustrative 29 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  30. 4.1.2 Rising focus of patients on personalized and patient-centric care Population Adopting Personalized Care in India, (%) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 Illustrative Illustrative 30 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  31. 4.1.3 Rapidly aging population of 153 Mn creating demand for PSPs Aging Demographic of India, (Mn) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2022 2024 2026 2028 2030 Illustrative Illustrative 31 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  32. 4.2 Market Restraints 4.2.2 Limited awareness among patients and lack of integration restrict the growth of PSPs 4.2.1 Increasing use of digital tools in PSPs raises concerns about data privacy and security Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. Illustrative Illustrative 32 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  33. India Patient Support Programs (PSP) Market Analysis 5. Competitive Landscape

  34. 5.1 Major Market Share Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Revenue of Major players in the India Patient Support Programs (PSP) Market ($ Mn) Company 10 In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability ▪ Company 9 Company 8 Company 7 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Company 6 Company 5 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Company 4 Company 3 Company 2 Company 1 Illustrative Illustrative 34 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  35. 5.2 Key Players in India Patient Support Programs (PSP) Market Here is the list of top 10 companies which will cover in the final report ▪ Janssen Pharmaceutical 1 6 Takeda Each company will have slides for ▪ Overview Key details Offerings Name of products Recent activities/ Press Coverage Distribution and Vendor Partners Mergers, Acquisitions and Collaboration Financials If there are specific companies that you would like to be included in the report, please let us know via email In order to obtain access to all of the information that you are seeking, you will need to purchase the final report o o 2 7 Roche Biocon Ltd o o o Dr. Reddy’s Laboratories 3 8 o o Pfizer o 4 9 Sanofi Cipla ▪ ▪ 10 5 Novartis Lupin Illustrative Illustrative 35 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  36. 5.2.1 Janssen – Johnson & Johnson Therapeutic Areas Founded in: 1953 ▪ Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is a pharmaceutical company at the forefront of medical research and development, focusing on various therapeutic areas ▪ With over 45,000 employees worldwide, Janssen is committed to reinventing healthcare and tackling society's most pressing health challenges ▪ It has been instrumental in developing a wide range of drugs for human medical disorders, including mental illness and cancer ➢ Oncology HQ: Beerse, Belgium ➢ Infectious Diseases Type: Private Revenue: $85.19 Bn (Global) ➢ Cardiology Website: Janssen ➢ Immunology Patient Support Program by Janssen Icare4u is a patient support program by Janssen, the pharmaceutical division of Johnson & Johnson Private Limited (J&J Pvt. Ltd) ▪ In collaboration with healthcare professionals (HCPs) and wellness experts, the Icare4u website aims to provide relevant information and support tools, to help patients and caregivers impacted by Chronic Immunological Diseases to manage their mental and emotional well-being ▪ It provides support for diseases such as Ulcerative Colitis, Rheumatoid Arthritis, among others ▪ 36 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  37. 5.2.1 Janssen – Johnson & Johnson (Continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers Johnson & Johnson has reached an agreement to acquire the rights to an experimental treatment for a skin disorder from the privately held company Numab Therapeutics This treatment, known as NM26, has recently completed early- stage clinical trials. NM26 is part of a class of medications known as bi-specific antibodies, which are engineered proteins capable of targeting two distinct disease pathways simultaneously ▪ Drug Acquisition $1.25 Bn May, 2024 ▪ Illustrative Illustrative 37 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  38. 5.2.1 Janssen – Johnson & Johnson (Continued) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Revenues ($Bn), 2020-2030 In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Breakdown of Net Revenue by Segment, 2023 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 1 2 3 4 Illustrative Illustrative 38 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  39. 5.2.2 Roche Solutions offered by Company Founded in: HQ: Type: Revenue: Website: Drugs for Telemedicine Recent Activity / Press Coverage Drugs Indications 39 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  40. 5.2.2 Roche (Continued) Partnerships Ecosystem Major Distribution Partners Major Vendor Partners 40 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  41. 5.2.2 Roche (Continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers 41 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  42. 5.2.2 Roche (Continued) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Revenues ($Bn), 2020-2030 xx xx xx In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Breakdown of Net Revenue by Segment, 2022 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 1 2 3 4 42 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  43. India Patient Support Programs (PSP) Market Analysis 6. Regulatory Landscape

  44. 6.1 Regulations in India Regulations For Patient Support Programs There is no single, comprehensive set of regulations governing patient support programs (PSPs) in India, however, there are indirect regulations and guidelines that influence their operation. Some key regulations for PSPs in India are as below: Drugs and Cosmetics Act & Rules (1940 & Rules): This act establishes the Drugs Controller General of India (DCGI) as the authority for regulating drugs and medical devices. This act emphasizes ethical marketing practices and fair competition within the pharmaceutical industry ▪ Medical Council of India (MCI) Ethics Regulations (2009): These regulations, now under the purview of the National Medical Commission (NMC), outline ethical considerations for interactions between doctors and pharmaceutical companies. This influences how pharmaceutical companies design and implement patient support programs to avoid undue influence on prescribing practices ▪ Department of Pharmaceuticals (DoP) Guidelines: The DoP occasionally issues guidelines related to interactions between pharmaceutical companies and healthcare professionals. These guidelines might touch upon acceptable practices for patient support programs ▪ Information Technology Act, 2000: The Information Technology Act governs electronic records and digital transactions in India. Patient support programs that involve the use of digital platforms or Patient Support Programs (PSP) must adhere to the data protection and privacy requirements under this Act. ▪ Illustrative Illustrative 44 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  45. 6.1 Regulations in India (Continued) Coverage Penetration (% Total Population) Source of Funding Spend on Healthcare (%of Current Health Expenditure) 100% 100% 100% 100% 100% 44.0% Government Expenditure xx 46.0% xx 47.7% xx xx xx 51.0% 51.8% Public Healthcare Coverage Private Health Insurance Out of Pocket 38.9% 37.1% 35.6% 31.5% 32.5% Private Coverage Other NA NA 2019 2020 2021 2022 2023 2017 2018 2019 2020 2021 2022 2023  Public healthcare coverage is provided by the government and includes programs like Medicare and Medicaid  Medicare is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities 6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy) 14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy) Reimbursement Market Trends ▪ Shift towards value-based care has been a significant trend in India healthcare system, with payers and providers increasingly focused on improving patient outcomes and reducing costs ▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care Illustrative Illustrative 45 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  46. 6.2 Reimbursement Process The reimbursement process in India healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient ▪ Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided ▪ Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud ▪ Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule ▪ Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost of the service, such as deductibles, co-payments, or co-insurance In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 46 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  47. 6.2 Reimbursement Process (Continued) The reimbursement process in India healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: MoH Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient ▪ Market Authorization Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided ▪ Private Payers Public Payers Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud ▪ Health Technology Assessment Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule ▪ 1 2 3 Coding Coverage Payment Coding depends on availability code while coverage and payment process decisions are made through an HTA. Illustrative Illustrative 47 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential

  48. A division of

  49. Life-sciences Market Research Reports you can trust We maintain an extensive database comprising over 30,000 syndicated market research reports within the pharmaceuticals and healthcare sector, offering a global, regional, and country-level perspective. Our services also include the provision of customized research reports, meticulously tailored to align with your specific requirements. www.insights10.com www.insights10.com

  50. Pharma (Diseases & Drugs) Digital Health Market Research Reports across various categories in healthcare OTC & Medical Devices Nutraceuticals At Insights10, our extensive report library spans a diverse range of categories within the field of life sciences. Clinical Trials Healthcare Services Rare Diseases www.insights10.com www.insights10.com

More Related